Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, indicating a small CMS or rendering update. The study details themselves appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-03T21:45:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.2, replacing v3.6.0, indicating a maintenance/version update to the page.
    Difference
    0.0%
    Check dated 2026-06-26T20:45:01.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The related topics/navigation section now omits the 'Lung cancer' and 'MedlinePlus Genetics' links, altering what contextual topics are surfaced for this study page.
    Difference
    0.1%
    Check dated 2026-06-19T17:42:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added recruitment status text No longer looking for participants and introduced new Help/Info sections such as How to Read a Study Record, Common Questions, How to Join a Study, and related topics including Lung cancer and MedlinePlus Genetics, and updated the revision tag to v3.6.0. Removed the Intervention / Treatment header from navigation and removed the older Revision: v3.5.5 tag.
    Difference
    0.3%
    Check dated 2026-06-12T16:21:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a newer page template/version. No substantive changes to the study record are evident.
    Difference
    0.0%
    Check dated 2026-06-05T11:21:48.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added Lung cancer and a related topics section with a MedlinePlus Genetics link to the page. This expands related-resource navigation without altering trial data.
    Difference
    0.1%
    Check dated 2026-05-29T06:00:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.